Global Epinastine Market Size, Status and Forecast 2020-2026

May 2020 | 92 pages | ID: G575DE731FC5EN
QYResearch

Abstracts

This report focuses on the global Epinastine status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Epinastine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.

The key players covered in this study

• Santen
• Merck
• Daiichi Sankyo
• Allergan
• Akorn
• Amneal Pharmaceuticals
• Apotex Corp
• Cypress Pharmaceuticals
• Boehringer Ingelheim

Market segment by Type, the product can be split into

• Tablets
• Capsule
• Eye Drops

Market segment by Application, split into

• Conjunctivitis
• Allergy
• Asthma
• Eczema
• Perennial Allergic Rhinitis
• Seasonal Allergic Rhinitis
• Psoriasis
• Pruritus
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global Epinastine status, future forecast, growth opportunity, key market and key players.
• To present the Epinastine development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of Epinastine are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Epinastine Revenue
1.4 Market Analysis by Type
  1.4.1 Global Epinastine Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Tablets
  1.4.3 Capsule
  1.4.4 Eye Drops
1.5 Market by Application
  1.5.1 Global Epinastine Market Share by Application: 2020 VS 2026
  1.5.2 Conjunctivitis
  1.5.3 Allergy
  1.5.4 Asthma
  1.5.5 Eczema
  1.5.6 Perennial Allergic Rhinitis
  1.5.7 Seasonal Allergic Rhinitis
  1.5.8 Psoriasis
  1.5.9 Pruritus
  1.5.10 Others
1.6 Study Objectives
1.7 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 Epinastine Market Perspective (2015-2026)
2.2 Epinastine Growth Trends by Regions
  2.2.1 Epinastine Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 Epinastine Historic Market Share by Regions (2015-2020)
  2.2.3 Epinastine Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 Epinastine Market Growth Strategy
  2.3.6 Primary Interviews with Key Epinastine Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top Epinastine Players by Market Size
  3.1.1 Global Top Epinastine Players by Revenue (2015-2020)
  3.1.2 Global Epinastine Revenue Market Share by Players (2015-2020)
  3.1.3 Global Epinastine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Epinastine Market Concentration Ratio
  3.2.1 Global Epinastine Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by Epinastine Revenue in 2019
3.3 Epinastine Key Players Head office and Area Served
3.4 Key Players Epinastine Product Solution and Service
3.5 Date of Enter into Epinastine Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global Epinastine Historic Market Size by Type (2015-2020)
4.2 Global Epinastine Forecasted Market Size by Type (2021-2026)

5 EPINASTINE BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global Epinastine Market Size by Application (2015-2020)
5.2 Global Epinastine Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America Epinastine Market Size (2015-2020)
6.2 Epinastine Key Players in North America (2019-2020)
6.3 North America Epinastine Market Size by Type (2015-2020)
6.4 North America Epinastine Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe Epinastine Market Size (2015-2020)
7.2 Epinastine Key Players in Europe (2019-2020)
7.3 Europe Epinastine Market Size by Type (2015-2020)
7.4 Europe Epinastine Market Size by Application (2015-2020)

8 CHINA

8.1 China Epinastine Market Size (2015-2020)
8.2 Epinastine Key Players in China (2019-2020)
8.3 China Epinastine Market Size by Type (2015-2020)
8.4 China Epinastine Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan Epinastine Market Size (2015-2020)
9.2 Epinastine Key Players in Japan (2019-2020)
9.3 Japan Epinastine Market Size by Type (2015-2020)
9.4 Japan Epinastine Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia Epinastine Market Size (2015-2020)
10.2 Epinastine Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Epinastine Market Size by Type (2015-2020)
10.4 Southeast Asia Epinastine Market Size by Application (2015-2020)

11 INDIA

11.1 India Epinastine Market Size (2015-2020)
11.2 Epinastine Key Players in India (2019-2020)
11.3 India Epinastine Market Size by Type (2015-2020)
11.4 India Epinastine Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America Epinastine Market Size (2015-2020)
12.2 Epinastine Key Players in Central & South America (2019-2020)
12.3 Central & South America Epinastine Market Size by Type (2015-2020)
12.4 Central & South America Epinastine Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Santen
  13.1.1 Santen Company Details
  13.1.2 Santen Business Overview and Its Total Revenue
  13.1.3 Santen Epinastine Introduction
  13.1.4 Santen Revenue in Epinastine Business (2015-2020))
  13.1.5 Santen Recent Development
13.2 Merck
  13.2.1 Merck Company Details
  13.2.2 Merck Business Overview and Its Total Revenue
  13.2.3 Merck Epinastine Introduction
  13.2.4 Merck Revenue in Epinastine Business (2015-2020)
  13.2.5 Merck Recent Development
13.3 Daiichi Sankyo
  13.3.1 Daiichi Sankyo Company Details
  13.3.2 Daiichi Sankyo Business Overview and Its Total Revenue
  13.3.3 Daiichi Sankyo Epinastine Introduction
  13.3.4 Daiichi Sankyo Revenue in Epinastine Business (2015-2020)
  13.3.5 Daiichi Sankyo Recent Development
13.4 Allergan
  13.4.1 Allergan Company Details
  13.4.2 Allergan Business Overview and Its Total Revenue
  13.4.3 Allergan Epinastine Introduction
  13.4.4 Allergan Revenue in Epinastine Business (2015-2020)
  13.4.5 Allergan Recent Development
13.5 Akorn
  13.5.1 Akorn Company Details
  13.5.2 Akorn Business Overview and Its Total Revenue
  13.5.3 Akorn Epinastine Introduction
  13.5.4 Akorn Revenue in Epinastine Business (2015-2020)
  13.5.5 Akorn Recent Development
13.6 Amneal Pharmaceuticals
  13.6.1 Amneal Pharmaceuticals Company Details
  13.6.2 Amneal Pharmaceuticals Business Overview and Its Total Revenue
  13.6.3 Amneal Pharmaceuticals Epinastine Introduction
  13.6.4 Amneal Pharmaceuticals Revenue in Epinastine Business (2015-2020)
  13.6.5 Amneal Pharmaceuticals Recent Development
13.7 Apotex Corp
  13.7.1 Apotex Corp Company Details
  13.7.2 Apotex Corp Business Overview and Its Total Revenue
  13.7.3 Apotex Corp Epinastine Introduction
  13.7.4 Apotex Corp Revenue in Epinastine Business (2015-2020)
  13.7.5 Apotex Corp Recent Development
13.8 Cypress Pharmaceuticals
  13.8.1 Cypress Pharmaceuticals Company Details
  13.8.2 Cypress Pharmaceuticals Business Overview and Its Total Revenue
  13.8.3 Cypress Pharmaceuticals Epinastine Introduction
  13.8.4 Cypress Pharmaceuticals Revenue in Epinastine Business (2015-2020)
  13.8.5 Cypress Pharmaceuticals Recent Development
13.9 Boehringer Ingelheim
  13.9.1 Boehringer Ingelheim Company Details
  13.9.2 Boehringer Ingelheim Business Overview and Its Total Revenue
  13.9.3 Boehringer Ingelheim Epinastine Introduction
  13.9.4 Boehringer Ingelheim Revenue in Epinastine Business (2015-2020)
  13.9.5 Boehringer Ingelheim Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. Epinastine Key Market Segments
Table 2. Key Players Covered: Ranking by Epinastine Revenue
Table 3. Ranking of Global Top Epinastine Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Epinastine Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablets
Table 6. Key Players of Capsule
Table 7. Key Players of Eye Drops
Table 8. Global Epinastine Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Epinastine Market Size by Regions (US$ Million): 2020 VS 2026
Table 10. Global Epinastine Market Size by Regions (2015-2020) (US$ Million)
Table 11. Global Epinastine Market Share by Regions (2015-2020)
Table 12. Global Epinastine Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 13. Global Epinastine Market Share by Regions (2021-2026)
Table 14. Market Top Trends
Table 15. Key Drivers: Impact Analysis
Table 16. Key Challenges
Table 17. Epinastine Market Growth Strategy
Table 18. Main Points Interviewed from Key Epinastine Players
Table 19. Global Epinastine Revenue by Players (2015-2020) (Million US$)
Table 20. Global Epinastine Market Share by Players (2015-2020)
Table 21. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2019)
Table 22. Global Epinastine by Players Market Concentration Ratio (CR5 and HHI)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Epinastine Product Solution and Service
Table 25. Date of Enter into Epinastine Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Epinastine Market Size by Type (2015-2020) (Million US$)
Table 28. Global Epinastine Market Size Share by Type (2015-2020)
Table 29. Global Epinastine Revenue Market Share by Type (2021-2026)
Table 30. Global Epinastine Market Size Share by Application (2015-2020)
Table 31. Global Epinastine Market Size by Application (2015-2020) (Million US$)
Table 32. Global Epinastine Market Size Share by Application (2021-2026)
Table 33. North America Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 34. North America Key Players Epinastine Market Share (2019-2020)
Table 35. North America Epinastine Market Size by Type (2015-2020) (Million US$)
Table 36. North America Epinastine Market Share by Type (2015-2020)
Table 37. North America Epinastine Market Size by Application (2015-2020) (Million US$)
Table 38. North America Epinastine Market Share by Application (2015-2020)
Table 39. Europe Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 40. Europe Key Players Epinastine Market Share (2019-2020)
Table 41. Europe Epinastine Market Size by Type (2015-2020) (Million US$)
Table 42. Europe Epinastine Market Share by Type (2015-2020)
Table 43. Europe Epinastine Market Size by Application (2015-2020) (Million US$)
Table 44. Europe Epinastine Market Share by Application (2015-2020)
Table 45. China Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 46. China Key Players Epinastine Market Share (2019-2020)
Table 47. China Epinastine Market Size by Type (2015-2020) (Million US$)
Table 48. China Epinastine Market Share by Type (2015-2020)
Table 49. China Epinastine Market Size by Application (2015-2020) (Million US$)
Table 50. China Epinastine Market Share by Application (2015-2020)
Table 51. Japan Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 52. Japan Key Players Epinastine Market Share (2019-2020)
Table 53. Japan Epinastine Market Size by Type (2015-2020) (Million US$)
Table 54. Japan Epinastine Market Share by Type (2015-2020)
Table 55. Japan Epinastine Market Size by Application (2015-2020) (Million US$)
Table 56. Japan Epinastine Market Share by Application (2015-2020)
Table 57. Southeast Asia Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 58. Southeast Asia Key Players Epinastine Market Share (2019-2020)
Table 59. Southeast Asia Epinastine Market Size by Type (2015-2020) (Million US$)
Table 60. Southeast Asia Epinastine Market Share by Type (2015-2020)
Table 61. Southeast Asia Epinastine Market Size by Application (2015-2020) (Million US$)
Table 62. Southeast Asia Epinastine Market Share by Application (2015-2020)
Table 63. India Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 64. India Key Players Epinastine Market Share (2019-2020)
Table 65. India Epinastine Market Size by Type (2015-2020) (Million US$)
Table 66. India Epinastine Market Share by Type (2015-2020)
Table 67. India Epinastine Market Size by Application (2015-2020) (Million US$)
Table 68. India Epinastine Market Share by Application (2015-2020)
Table 69. Central & South America Key Players Epinastine Revenue (2019-2020) (Million US$)
Table 70. Central & South America Key Players Epinastine Market Share (2019-2020)
Table 71. Central & South America Epinastine Market Size by Type (2015-2020) (Million US$)
Table 72. Central & South America Epinastine Market Share by Type (2015-2020)
Table 73. Central & South America Epinastine Market Size by Application (2015-2020) (Million US$)
Table 74. Central & South America Epinastine Market Share by Application (2015-2020)
Table 75. Santen Company Details
Table 76. Santen Business Overview
Table 77. Santen Product
Table 78. Santen Revenue in Epinastine Business (2015-2020) (Million US$)
Table 79. Santen Recent Development
Table 80. Merck Company Details
Table 81. Merck Business Overview
Table 82. Merck Product
Table 83. Merck Revenue in Epinastine Business (2015-2020) (Million US$)
Table 84. Merck Recent Development
Table 85. Daiichi Sankyo Company Details
Table 86. Daiichi Sankyo Business Overview
Table 87. Daiichi Sankyo Product
Table 88. Daiichi Sankyo Revenue in Epinastine Business (2015-2020) (Million US$)
Table 89. Daiichi Sankyo Recent Development
Table 90. Allergan Company Details
Table 91. Allergan Business Overview
Table 92. Allergan Product
Table 93. Allergan Revenue in Epinastine Business (2015-2020) (Million US$)
Table 94. Allergan Recent Development
Table 95. Akorn Company Details
Table 96. Akorn Business Overview
Table 97. Akorn Product
Table 98. Akorn Revenue in Epinastine Business (2015-2020) (Million US$)
Table 99. Akorn Recent Development
Table 100. Amneal Pharmaceuticals Company Details
Table 101. Amneal Pharmaceuticals Business Overview
Table 102. Amneal Pharmaceuticals Product
Table 103. Amneal Pharmaceuticals Revenue in Epinastine Business (2015-2020) (Million US$)
Table 104. Amneal Pharmaceuticals Recent Development
Table 105. Apotex Corp Company Details
Table 106. Apotex Corp Business Overview
Table 107. Apotex Corp Product
Table 108. Apotex Corp Revenue in Epinastine Business (2015-2020) (Million US$)
Table 109. Apotex Corp Recent Development
Table 110. Cypress Pharmaceuticals Business Overview
Table 111. Cypress Pharmaceuticals Product
Table 112. Cypress Pharmaceuticals Company Details
Table 113. Cypress Pharmaceuticals Revenue in Epinastine Business (2015-2020) (Million US$)
Table 114. Cypress Pharmaceuticals Recent Development
Table 115. Boehringer Ingelheim Company Details
Table 116. Boehringer Ingelheim Business Overview
Table 117. Boehringer Ingelheim Product
Table 118. Boehringer Ingelheim Revenue in Epinastine Business (2015-2020) (Million US$)
Table 119. Boehringer Ingelheim Recent Development
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global Epinastine Market Share by Type: 2020 VS 2026
Figure 2. Tablets Features
Figure 3. Capsule Features
Figure 4. Eye Drops Features
Figure 5. Global Epinastine Market Share by Application: 2020 VS 2026
Figure 6. Conjunctivitis Case Studies
Figure 7. Allergy Case Studies
Figure 8. Asthma Case Studies
Figure 9. Eczema Case Studies
Figure 10. Perennial Allergic Rhinitis Case Studies
Figure 11. Seasonal Allergic Rhinitis Case Studies
Figure 12. Psoriasis Case Studies
Figure 13. Pruritus Case Studies
Figure 14. Others Case Studies
Figure 15. Epinastine Report Years Considered
Figure 16. Global Epinastine Market Size YoY Growth 2015-2026 (US$ Million)
Figure 17. Global Epinastine Market Share by Regions: 2020 VS 2026
Figure 18. Global Epinastine Market Share by Regions (2021-2026)
Figure 19. Porter's Five Forces Analysis
Figure 20. Global Epinastine Market Share by Players in 2019
Figure 21. Global Top Epinastine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Epinastine as of 2019
Figure 22. The Top 10 and 5 Players Market Share by Epinastine Revenue in 2019
Figure 23. North America Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Europe Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. China Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Japan Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Southeast Asia Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. India Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Central & South America Epinastine Market Size YoY Growth (2015-2020) (Million US$)
Figure 30. Santen Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Santen Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 32. Merck Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Merck Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 34. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Daiichi Sankyo Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 36. Allergan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Allergan Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 38. Akorn Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. Akorn Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 40. Amneal Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Amneal Pharmaceuticals Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 42. Apotex Corp Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. Apotex Corp Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 44. Cypress Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Cypress Pharmaceuticals Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 46. Boehringer Ingelheim Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. Boehringer Ingelheim Revenue Growth Rate in Epinastine Business (2015-2020)
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation